Useful extend-release chitosan tablets with high antioxidant activity

Pharmaceutics

Volumn 2, Issue 2, 2010, Pages 245-257

  Yasufuku, Taira ^a   Anraku, Makoto ^a   Kondo, Yuko ^a   Hata, Toshiyuki ^a   Hirose, Junzo ^a   Kobayashi, Nobuyuki ^b   Tomida, Hisao ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

^b Dainichiseika Color & Chemicals Mfg Co Ltd   (Japan)

Author keywords

Antioxidant; Chitosan; Extend release; Matrix tablet; Molecular weight; Radicals

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2,2' AZINOBIS(3 ETHYLBENZOTHIAZOLINE 6 SULFONIC ACID); CARBON DISULFIDE; CHITOSAN; CUPRIC ION; HYDROXYL GROUP; SUPEROXIDE; THEOPHYLLINE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENCY; ELECTRON SPIN RESONANCE; IN VITRO STUDY; MOLECULAR WEIGHT; OXIDATIVE STRESS; SPRAY DRYING; TABLET FORMULATION;

EID: 79952133211     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics2020245     Document Type: Article

References (37)

1. Miyazaki, Y.; Tanaka, Y.; Yakou, S.; Takayama, K. In vivo drug release from hydrophilic dextran tablets capable of forming polyion complex. J. Controlled Release 2006, 114, 47-52.
2. Liew, C.V.; Chan, L.W.; Ching, L.; Heng, P.W. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int. J. Pharm. 2006, 309, 25-37.
3. Pitt, C.G. The controlled parenteral delivery of peptides and protein. Int. J. Pharm. 1990, 59, 173-196.
4. Aiedeh, K.; Taha, M.O. Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads. Eur. J. Pharm. Sci. 2001,13,159-168.
5. Patel, V.R.; Amiji, M.M. Preparation and characterization of freeze-dried chitosan-poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach. Pharm. Res. 1996, 13, 588-593.
6. Puttipipatkhachorn, S.; Nunthanid, J.; Yamamoto, K.; Peck, G.E. Drug physical state and drugpolymer interaction on drug release from chitosan matrix films. J. Controlled Release 2001, 75, 143-153.
7. Oungbho, K.; Muller, B.W. Chitosan sponges as sustained release drug carriers. Int. J. Pharm. 1997, 156, 229-237.
8. He, P.; Davis, S.S.; Illum, L. Chitosan microspheres prepared by spray drying. Int. J. Pharm. 1999, 187, 53-65.
9. Xue, C.; Yu, G.; Hirata, T.; Terao, J.; Lin, H. Antioxidative activities of several marine polysaccharides evaluated in a phosphatidylcholine-liposomal suspension and organic solvents. Biosci. Biotechnol. Biochem. 1998, 62, 206-209.
10. Chiang, M.T.; Yao, H.T.; Chen, H.C. Effect of dietary chitosans with different viscosity on plasma lipids and lipid peroxidation in rats fed on a diet enriched with cholesterol. Biosci. Biotechnol. Biochem. 2000, 64, 965-971.
11. Anraku, M.; Kabashima, M.; Namura, H.; Maruyama, T.; Otagiri, M.; Gebicki, J.M.; Furutani, N.; Tomida, H. Antioxidant protection of human serum albumin by chitosan. Int. J. Biol. Macromol. 2008, 43, 159-164.
12. Santhosh, S.; Sini, T.K.; Anandan, R.; Mathew, P.T. Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats. Toxicology 2006, 219, 53-59.
13. Yoon, H.J.; Moon, M.E.; Park, H.S.; Kim, H.W.; Im, S.Y.; Lee, J.H.; Kim, Y.H. Effects of chitosan oligosaccharide (COS) on the glycerol-induced acute renal failure in vitro and in vivo. Food Chem. Toxicol. 2008, 46, 710-716.
14. Anraku, M.; Fujii, T.; Furutani, N.; Kadowaki, D.; Maruyama, T.; Otagiri, M.; Gebicki, J.M.; Tomida, H. Antioxidant effects of a dietary supplement: reduction of indices of oxidative stress in normal subjects by water-soluble chitosan. Food Chem. Toxicol. 2009,47,104-109.
15. Kogure, K.; Goto, S.; Abe, K.; Ohiwa, C.; Akasu, M.; Terada, H. Potent antiperoxidation activity of the bisbenzylisoquinoline alkaloid cepharanthine: the amine moiety is responsible for its pHdependent radical scavenge activity. Biochim. Biophys. Acta. 1999, 1426, 133-142.
16. Rosen, G.M.; Rauckman, E.J. Spin trapping of superoxide and hydroxyl radicals. In Methods in enzymology; Packer, L., Ed.; Academic Press: Orlando, F.L., USA, 1984; Volume 105, pp. 189-209.
17. Guo, Q.; Zhao, B.; Shen, S.; Hou, J.; Hu, J.; Xin, W. ESR study on the structure-antioxidantactivity relationship of tea catechins and their epimers. Biochim. Biophys. Acta. 1999, 1427, 13-23.
18. Leelarungrayub, N.; Rattanapanone, V.; Chanarat, N.; Gebicki, J.M. Quantitative evaluation of the antioxidant properties of garlic and shallot preparations. Nutrition 2006, 22, 266-274.
19. Butterfield, D.A.; Lauderback, C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radical Biol. Med. 2002, 2, 1050-1060.
20. Halliwell, B.; Gutteridge, J.M. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 1990, 280, 1-8.
21. Péterszegi, G.; Robert, A.M.; Robert, L. Protection by L-fucose and fucose-rich polysaccharides against ROS-produced cell death in presence of ascorbate. Biomed. Pharmacother. 2003, 57, 130-133.
22. Kim, S.K.; Rajapakse, N. Enzymatic production and biological activities of chitosan oligosaccharides. Carbohydr. Polym. 2005, 62, 357-368.
23. Soares, J.R.; Dins, T.C.P.; Cunha, A.P.; Almeida, L.M. Antioxidant activities of some extracts of Thymus zygis. Free Radical Res. 1997, 26, 469-478.
24. Park, P.J.; Je, J.Y.; Kim, S.K. Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry. J. Agric. Food Chem. 2003, 51, 4624-4627.
25. Xie, W.; Xu, P.; Liu, Q. Antioxidant activity of watersoluble chitosan derivatives. Bioorg. Med. Chem. Lett. 2001, 11, 1699-1701.
26. Nellore, R.V.; Rekhi, G.S.; Hussain, A.S.; Tillman, L.G.; Augsburger, L.L. Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration. J. Controlled Release 1998, 50, 247-256
27. Kranz, H.; Guthmann, C.; Wagner, T.; Lipp, R.; Reiinhard, J. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. Eur. J. Pharm. Sci. 2005, 26, 47-53.
28. Nigalaye, A.G.; Adusumili, P.; Bolton, S. Investigation of prolonged drug release from matrix formulations of chitosan. Drug Dev. Ind. Pharm. 1990, 16, 449-467.
29. Sawayanagi, Y.; Nambu, N.; Nagai, T. Direct compressed tablets containing chitin. Chem. Pharm. Bull. 1982, 30, 4216-4218.
30. Knapczyk, J. Excipient ability of chitosan for direct tableting. Int. J. Pharm. 1993, 89, 1-7.
31. Takeuchi, H.; Yasuji, T.; Yamamoto, H.; Kawashima, Y. Spray dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry coated tablet having a time controlled releasing function. Pharm. Res. 2000, 17, 94-99.
32. Sukaya, T.; Murakami, H.; Katayama, H. Preparation of minute particles of chitosan. J.P. Patent JP 630,020,302 A2, January 25, 1988.
33. Yabe, H.; Itoyama, M.; Kawamura, Y. Manufacture of chitosan and chitin porous microparticles. J.P. Patent JP 632,210,101 A2, August 31, 1988.
34. Yamanami, T.; Tsuchida, S.; Seki, M. Preparation of chitosan powder for pharmaceutics. J.P. Patent JP 63,017,902 A2, January 25, 1988.
35. Tohda, Y.; Muraki, M.; Iwanaga, T.; Kubo, H.; Fukuoka, M.; Nakajima, S. The effect of theophylline on blood and sputum eosinophils and ECP in patients with bronchial asthma. Int. J. Immunopharm. 1998, 20, 173-181.
36. Finnerty, J.P.; Lee, C.; Wilson, S.; Madden, J.; Djukanovic, R.; Holgate, S.T. Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlledparallel group study. Eur. Resp. J. 1996, 9, 1672-1677.
37. Mellstrand, T.; Svedmyr, N.; Fagerström, P.O. Absorption of theophylline from conventional and sustained-release tablets. Eur. J. Resp. Dis. Suppl. 1980, 109, 54-60